CCL4 and Sepsis: First, we observed that in secondary S. aureus pneumonia induced by sepsis, recombinant CCL4 could improve lung pathology and lung injury, increase the clearance rate of bacteria from the lung and blood, reduce lung injury and mortality, and effectively promote macrophage recruitment in the lungs (Figures 5(a)–5(i)).